CLOVIS ONCOLOGY, INC.

Profile

Company Names

CLOVIS ONCOLOGY, INC.

Addresses

2525 28TH STREET, SUITE 100, BOULDER, CO 80301

2525 28TH STREET, SUITE 100, BOULDER, CO 80301

1871 FOLSOM STREET, BOULDER, CO 80302

Phone Numbers

(720) 220-9122
(303) 625-5000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$358,262,756.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-11-19 
$191,962,756.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2011-05-25 
$20,000,000.00 
INDEFINITE 
INDEFINITE 
Debt 
1
2009-05-15 
$146,300,000.00 
$146,300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
R. 
ALLEN 
EXECUTIVE OFFICER
CLOVIS ONCOLOGY, INC.
BRIAN 
G. 
ATWOOD 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  PHASERX INC   |  OPGEN INC   |  TRIUS THERAPEUTICS INC   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  PHASERX, INC.   |  CLOVIS ONCOLOGY, INC.   |  VERACYTE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
M. 
JAMES 
BARRET 
DIRECTOR
CLOVIS ONCOLOGY, INC.
JAMES 
C. 
BLAIR 
DIRECTOR
ZOGENIX INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  INTEGENX INC   |  APPLIED PROTEOMICS, INC.   |  CLOVIS ONCOLOGY, INC.   |  DOMAIN PARTNERS IX, L.P.   |  ATYR PHARMA INC   |  GENE SCIENCES, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  CHROMACODE, INC.   |  AXIAL THERAPEUTICS, INC.
KEITH 
 
FLAHERTY 
DIRECTOR
CLOVIS ONCOLOGY, INC.   |  LOXO ONCOLOGY, INC.   |  STRATA ONCOLOGY, INC.   |  CHECKMATE PHARMACEUTICALS, INC.   |  KINNATE BIOPHARMA INC.   |  SCORPION THERAPEUTICS, INC.   |  ANTARES THERAPEUTICS, INC.
GINGER 
L. 
GRAHAM 
DIRECTOR
SUREFIRE MEDICAL, INC.   |  CLOVIS ONCOLOGY, INC.
STEVEN 
L. 
HOERTER 
EXECUTIVE OFFICER
CLOVIS ONCOLOGY, INC.
GILLIAN 
C. 
IVERS-READ 
EXECUTIVE OFFICER
CLOVIS ONCOLOGY, INC.
PAUL 
 
KLINGENSTEIN 
DIRECTOR
ENTEROMEDICS INC   |  AVIIR INC   |  VERTIFLEX INC   |  POSIT SCIENCE CORP   |  CONATUS PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS INC   |  MC10, INC.   |  ANACOR PHARMACEUTICALS, INC.   |  CLOVIS ONCOLOGY, INC.   |  IDUN PHARMACEUTICALS INC
PATRICK 
J. 
MAHAFFY 
EXECUTIVE OFFICER, DIRECTOR
CLOVIS ONCOLOGY, INC.
ERLE 
T. 
MAST 
EXECUTIVE OFFICER
ZOGENIX INC   |  CLOVIS ONCOLOGY, INC.   |  SOMAXON PHARMACEUTICALS, INC.
EDWARD 
J. 
MCKINLEY 
DIRECTOR
CLOVIS ONCOLOGY, INC.
THORLEF 
 
SPICKSCHEN 
DIRECTOR
CLOVIS ONCOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-11-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-11-19 
2011-06-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-05-25 
2011-05-18
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
2010-05-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
2009-06-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#